Analysis of microbiology and antibiotic susceptibility of perioperative urinary tract infection in patients undergoing hip or knee arthroplasty_West China Medical Journal

Authors：

CHEN Zhi , ZHOU Kai , WANG Duan ,  ZHOU Zongke , SHEN Bin , YANG Jing , KANG Pengde , PEI Fuxing

Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

ZHOU Zongke, Email: zongke@126.com

Keywords：

Arthroplasty, hip, knee; Urinary tract infection; Bacterial sensitivity

DOI：

10.7507/1002-0179.201512159

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the microbiological etiology and antibiotic susceptibility of periopertive urinary tract infection (UTI) in patients undergoing hip or knee arthroplasty, so as to provide recommendations for antibiotic treatment. Methods A retrospective review was conducted for patients with perioperative UTI who underwent hip or knee arthroplasty between January 1st, 2013 and October 1st, 2015. Microbiological data and antibiotic susceptibility of bacteria were analyzed. Results A total of 117 strains of bacteria were identified, including 11 types of species. Among the organisms cultured, 86.3% (101 strains) were gram-negative bacteria, in which Escherichia coli was the most common causative organism (70.9%, 83 strains), followed by Klebsiella species (7.7%, 9 strains) and Proteus mirabilis (3.4%, 4 strains). And among the gram-positive bacteria detected, the proportion of Enterococcus faecalis and Feces Enterococcus was 6.8% (8 strains) and 3.4% (4 strains), respectively. The bacteria showed highly resistance to cephalosporins, quinolones and sulfonamides, but showed high sensitive to nitrofurantoin, carbopenems, the enzyme inhibitor complex and aminoglycoside antibiotics. Conclusions There is a diversity of bacteria involved in UTI, and the top 3 pathogens are Escherichia coli, Enterococcus faecalis and Klebsiella species. The resistance rate is high, and nitrofurantoin, amilacin, piperacillin-tazobactam, cefoperazone-sulbactam are the recommended antibiotics to treat the UTI, but the antibiotic should be adjusted according to susceptibility results.

Citation： CHEN Zhi, ZHOU Kai, WANG Duan, ZHOU Zongke, SHEN Bin, YANG Jing, KANG Pengde, PEI Fuxing. Analysis of microbiology and antibiotic susceptibility of perioperative urinary tract infection in patients undergoing hip or knee arthroplasty. West China Medical Journal, 2017, 32(9): 1387-1390. doi: 10.7507/1002-0179.201512159 Copy

1.	Iorio R, Whang W, Healy WL, et al. The utility of bladder catheterization in total hip arthroplasty. Clin Orthop Relat Res, 2005(432): 148-152.
2.	Ridgeway S, Wilson J, Charlet A, et al. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br, 2005, 87(6): 844-850.
3.	Pitout JD. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert Rev Anti Infect Ther, 2012, 10(10): 1165-1176.
4.	Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis, 2005, 40(5): 643-654.
5.	Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis, 2011, 52(5): e103-e120.
6.	趙靜, 陳光輝, 王山梅. 尿路感染患者病原菌分布及耐藥性分析. 中華實用診斷與治療雜志, 2014, 28(1): 103-104.
7.	Cordero-Ampuero J, de Dios M. What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties?. Clin Orthop Relat Res, 2010, 468(12): 3268-3277.
8.	Otermin I, Rivero M, Hidalgo A. Is it necessary to delay or to put off surgery in the case of possible asymptomatic bacteriuria and orthopaedic surgery with implants?. Enferm Infec Microbiol Clin, 2009, 27(4): 252-253.
9.	Linhares I, Raposo T, Rodrigues A, et al. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis, 2013, 13(1): 19.
10.	喬廬東, 陳山, 楊勇, 等. 國內不同類型下尿路感染患者尿路病原菌構成及藥敏分析的多中心研究. 中華泌尿外科雜志, 2015, 36(9): 690-693.
11.	尿路感染診斷與治療中國專家共識編寫組. 尿路感染診斷與治療中國專家共識(2015版)——尿路感染抗菌藥物選擇策略及特殊類型尿路感染的治療建議. 中華泌尿外科雜志, 2015, 36(4): 245-248.
12.	Pickard R, Bartoletti R, Bjerklund-Johansen TE, et al. European Association of Urology 2015. Guidelines on urological infections. Hactahobn, 2015, 3(13): 47-58.
13.	張原琪, 黃里, 劉燕. 尿路感染病原菌分布及耐藥性分析. 中華醫院感染學雜志, 2011, 21(13): 2852-2854.
14.	Lai B, Zheng B, Li Y, et al. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012). BMC Infect Dis, 2014, 14(1): 66.
15.	Gupta K, Bhadelia N. Management of urinary tract infections from multidrug-resistant organisms. Infect Dis Clin North Am, 2014, 28(1): 49-59.
16.	吳澤才, 吳少群, 向成玉. 2006-2010 年尿路感染病原菌分布及耐藥性分析. 中華醫院感染學雜志, 2012, 22(6): 1296-1299.

1. Iorio R, Whang W, Healy WL, et al. The utility of bladder catheterization in total hip arthroplasty. Clin Orthop Relat Res, 2005(432): 148-152.
2. Ridgeway S, Wilson J, Charlet A, et al. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br, 2005, 87(6): 844-850.
3. Pitout JD. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert Rev Anti Infect Ther, 2012, 10(10): 1165-1176.
4. Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis, 2005, 40(5): 643-654.
5. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis, 2011, 52(5): e103-e120.
6. 趙靜, 陳光輝, 王山梅. 尿路感染患者病原菌分布及耐藥性分析. 中華實用診斷與治療雜志, 2014, 28(1): 103-104.
7. Cordero-Ampuero J, de Dios M. What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties?. Clin Orthop Relat Res, 2010, 468(12): 3268-3277.
8. Otermin I, Rivero M, Hidalgo A. Is it necessary to delay or to put off surgery in the case of possible asymptomatic bacteriuria and orthopaedic surgery with implants?. Enferm Infec Microbiol Clin, 2009, 27(4): 252-253.
9. Linhares I, Raposo T, Rodrigues A, et al. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis, 2013, 13(1): 19.
10. 喬廬東, 陳山, 楊勇, 等. 國內不同類型下尿路感染患者尿路病原菌構成及藥敏分析的多中心研究. 中華泌尿外科雜志, 2015, 36(9): 690-693.
11. 尿路感染診斷與治療中國專家共識編寫組. 尿路感染診斷與治療中國專家共識(2015版)——尿路感染抗菌藥物選擇策略及特殊類型尿路感染的治療建議. 中華泌尿外科雜志, 2015, 36(4): 245-248.
12. Pickard R, Bartoletti R, Bjerklund-Johansen TE, et al. European Association of Urology 2015. Guidelines on urological infections. Hactahobn, 2015, 3(13): 47-58.
13. 張原琪, 黃里, 劉燕. 尿路感染病原菌分布及耐藥性分析. 中華醫院感染學雜志, 2011, 21(13): 2852-2854.
14. Lai B, Zheng B, Li Y, et al. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012). BMC Infect Dis, 2014, 14(1): 66.
15. Gupta K, Bhadelia N. Management of urinary tract infections from multidrug-resistant organisms. Infect Dis Clin North Am, 2014, 28(1): 49-59.
16. 吳澤才, 吳少群, 向成玉. 2006-2010 年尿路感染病原菌分布及耐藥性分析. 中華醫院感染學雜志, 2012, 22(6): 1296-1299.

Previous Article
Evidence-based treatment for multilevel cervical spondylotic myelopathy
Next Article
Clinical therapeutic analysis of 19 patients with HIV/AIDS treated by otolaryngology surgery

West China Medical Journal

Analysis of microbiology and antibiotic susceptibility of perioperative urinary tract infection in patients undergoing hip or knee arthroplasty

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content